Cargando…

Oleoylethanolamide facilitates PPARa and TFEB signaling and attenuates Ab pathology in a mouse model of Alzheimer’s disease

Mostrar otras versiones (1)

Emerging evidence implicates impaired microglia function and dysregulation of lipid metabolism in Alzheimer’s disease (AD). Oleoylethanolamide (OEA), an endogenous lipid and PPARα agonist, has been shown to promote longevity in C. elegans through regulation of lysosome-to-nucleus signaling and cellu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Comerota, Michele, Gedam, Manasee, Xiong, Wen, Jin, Feng, Deng, Lisheng, Wang, Meng, Wang, Jin, Zheng, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal Experts 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9882642/ https://www.ncbi.nlm.nih.gov/pubmed/36711875 http://dx.doi.org/10.21203/rs.3.rs-2484513/v1

Ejemplares similares

Oleoylethanolamide facilitates PPARα and TFEB signaling and attenuates Aβ pathology in a mouse model of Alzheimer’s disease
por: Comerota, Michele M., et al.
Publicado: (2023)

Complement C3aR depletion reverses HIF-1α–induced metabolic impairment and enhances microglial response to Aβ pathology
por: Gedam, Manasee, et al.
Publicado: (2023)

FoxO3 deficiency in cortical astrocytes leads to impaired lipid metabolism and aggravated amyloid pathology
por: Du, Shuqi, et al.
Publicado: (2021)

Oleoylethanolamide, Neuroinflammation, and Alcohol Abuse
por: Orio, Laura, et al.
Publicado: (2019)

Oleoylethanolamide attenuates cocaine-primed reinstatement and alters dopaminergic gene expression in the striatum
por: González-Portilla, Macarena, et al.
Publicado: (2023)

mTOR-dependent TFEB activation and TFEB overexpression enhance autophagy-lysosome pathway and ameliorate Alzheimer's disease-like pathology in diabetic encephalopathy
por: Cheng, Lizhen, et al.
Publicado: (2023)

Atheroprotective Effect of Oleoylethanolamide (OEA) Targeting Oxidized LDL
por: Fan, Angran, et al.
Publicado: (2014)

MicroRNA-141 Represses HBV Replication by Targeting PPARA
por: Hu, Wei, et al.
Publicado: (2012)

Significance of PPARA as a Treatment Target for Chronic Lymphocytic Leukemia
por: Xiang, Xixi, et al.
Publicado: (2023)

Oleoylethanolamide treatment reduces neurobehavioral deficits and brain pathology in a mouse model of Gulf War Illness
por: Joshi, Utsav, et al.
Publicado: (2018)

Genetic Variability of RXRB, PPARA, and PPARG in Wegener's Granulomatosis
por: Wieczorek, Stefan, et al.
Publicado: (2009)

Theranostic F-SLOH mitigates Alzheimer's disease pathology involving TFEB and ameliorates cognitive functions in Alzheimer's disease models
por: Iyaswamy, Ashok, et al.
Publicado: (2022)

Intermittent hypoxia therapy ameliorates beta-amyloid pathology via TFEB-mediated autophagy in murine Alzheimer's disease
por: Wang, Xueting, et al.
Publicado: (2023)

Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells
por: Chen, Ling, et al.
Publicado: (2015)

Gut microbiota and oleoylethanolamide in the regulation of intestinal homeostasis
por: De Filippo, Carlotta, et al.
Publicado: (2023)

Correction: MicroRNA-141 Represses HBV Replication by Targeting PPARA
por: Hu, Wei, et al.
Publicado: (2012)

Long non-coding RNA Gm15441 attenuates hepatic inflammasome activation in response to PPARA agonism and fasting
por: Brocker, Chad N., et al.
Publicado: (2020)

Sleep deprivation increases oleoylethanolamide in human cerebrospinal fluid
por: Koethe, Dagmar, et al.
Publicado: (2009)

Oleoylethanolamide‐induced anorexia in rats is associated with locomotor impairment
por: Fedele, Shahana, et al.
Publicado: (2018)

Identification of oleoylethanolamide as an endogenous ligand for HIF-3α
por: Diao, Xiaotong, et al.
Publicado: (2022)

Oleoylethanolamide induces eosinophilic airway inflammation in bronchial asthma
por: Kwon, Eun-Kyung, et al.
Publicado: (2021)

Author Correction: Oleoylethanolamide treatment reduces neurobehavioral deficits and brain pathology in a mouse model of Gulf War Illness
por: Joshi, Utsav, et al.
Publicado: (2019)

Hepatic MIR20B promotes nonalcoholic fatty liver disease by suppressing PPARA
por: Lee, Yo Han, et al.
Publicado: (2021)

Transcriptional and phenotypic comparisons of Ppara knockout and siRNA knockdown mice
por: De Souza, Angus T., et al.
Publicado: (2006)

Sistemas anaerobios avanzados ppara el tratamientos de aguas residuales
por: Peña Gálvez, Miguel Angel
Publicado: (1996)

Gene repression through epigenetic modulation by PPARA enhances hepatocellular proliferation
por: Aibara, Daisuke, et al.
Publicado: (2022)

Keratin 79 is a PPARA target that is highly expressed by liver damage
por: Kim, Donghwan, et al.
Publicado: (2023)

Oleoylethanolamide as a New Therapeutic Strategy to Alleviate Doxorubicin-Induced Cardiotoxicity
por: Qin, Yeyu, et al.
Publicado: (2022)

Oleoylethanolamide and Palmitoylethanolamide Protect Cultured Cortical Neurons Against Hypoxia
por: Portavella, Manuel, et al.
Publicado: (2018)

Oleoylethanolamide Ameliorates Dextran Sulfate Sodium-Induced Colitis in Rats
por: Otagiri, Shinsuke, et al.
Publicado: (2020)

Effects of Alcohol Binge Drinking and Oleoylethanolamide Pretreatment in the Gut Microbiota
por: Rodríguez-González, Alicia, et al.
Publicado: (2021)

Proteomics of Vitreous Humor Reveals PPARA, RXR, and LXR Are Possible Upstream Regulators of Proliferative Diabetic Retinopathy
por: Li, Siyan, et al.
Publicado: (2021)

Celastrol enhances transcription factor EB (TFEB)-mediated autophagy and mitigates Tau pathology: Implications for Alzheimer's disease therapy
por: Yang, Chuanbin, et al.
Publicado: (2022)

TFEB-Mediated Lysosomal Restoration Alleviates High Glucose-Induced Cataracts Via Attenuating Oxidative Stress
por: Sun, Yan, et al.
Publicado: (2022)

PPARA Intron Polymorphism Associated with Power Performance in 30-s Anaerobic Wingate Test
por: Petr, Miroslav, et al.
Publicado: (2014)

A splicing variant of TFEB negatively regulates the TFEB-autophagy pathway
por: Park, Jee-Yun, et al.
Publicado: (2021)

Oleoylethanolamide Alleviates Hepatic Ischemia-Reperfusion Injury via Inhibiting Endoplasmic Reticulum Stress-Associated Apoptosis
por: Qi, Shunli, et al.
Publicado: (2022)

Novel Insight into Functions of Transcription Factor EB (TFEB) in Alzheimer’s Disease and Parkinson’s Disease
por: Yang, Jing, et al.
Publicado: (2023)

Administration of URB597, Oleoylethanolamide or Palmitoylethanolamide Increases Waking and Dopamine in Rats
por: Murillo-Rodríguez, Eric, et al.
Publicado: (2011)

TFEB acetylation promotes lysosome biogenesis and ameliorates Alzheimer’s disease–relevant phenotypes in mice
por: Li, Tianyou, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_po6sl9c1nuf4cksb2qq53fns3c